Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion

INTRODUCTION: Intravenous immunoglobulin (IVIG) has been widely used to treat the hemolytic disease of the newborn (HDN). Although it has been shown that IVIG treatment reduces the duration of phototherapy and hospitalization, the use of IVIG in hemolytic disease due to ABO incompatibility has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Okulu, Emel, Erdeve, Omer, Kilic, Ilknur, Olukman, Ozgur, Calkavur, Sebnem, Buyukkale, Gokhan, Cetinkaya, Merih, Ulubas, Dilek, Demirel, Nihal, Hanta, Deniz, Ertugrul, Sabahattin, Gultekin, Nazli Dilay, Tuncer, Oguz, Demir, Nihat, Bilgin, Leyla, Narli, Nejat, Yildiz, Duran, Terek, Demet, Koroglu, Ozge Altun, Seren, Canan, Ozyazici, Elif, Ozdemir, Ramazan, Turgut, Hatice, Narter, Fatma, Akin, Yasemin, Ozyazici, Ahmet, Zenciroglu, Aysegul, Asker, Huseyin Selim, Gokmen, Zeynel, Salihli, Musa, Bulbul, Ali, Zubarioglu, Umut, Atasay, Begum, Koc, Esin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095978/
https://www.ncbi.nlm.nih.gov/pubmed/35573949
http://dx.doi.org/10.3389/fped.2022.864609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095978/
https://www.ncbi.nlm.nih.gov/pubmed/35573949
http://dx.doi.org/10.3389/fped.2022.864609

Ejemplares similares